November 9, 2009 – Boston Scientific Corp. today announced the launch of its COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and the TELIGEN implantable cardioverter defibrillator (ICD) in Japan.

November 9, 2009 — PAREXEL International Corp., a global biopharmaceutical services provider, announced today that it has enhanced its cardiac safety capabilities for early-phase clinical development through an alliance with Mortara Instrument Inc., which manufactures and distributes electrocardiogram (ECG) devices and related technology worldwide.

November 9, 2009 – Boston Scientific Corp. said Friday it reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific’s 2006 acquisition of Guidant.

November 6, 2009 — Stereotaxis received notice this week that its Celsius RMT ThermoCool catheter received CE mark for distribution in the European market.

November 4, 2009 – CardioNet Inc. said this week the Centers for Medicare and Medicaid Services (CMS) has not established a national pricing reimbursement rate for mobile cardiovascular telemetry (CPT Code 93229) in the Medicare final rule for the physician fee schedule for calendar year 2010.

November 4, 2009 — BIOTRONIK Inc. this week announced the results from site preparation, antibiotic use and infection sub-analysis from the REPLACE Registry.

November 6, 2009 – Edwards Lifesciences Corp. today announced the first successful Japanese implants of a transcatheter aortic heart valve using its Edwards SAPIEN valve.

The transfemoral and transapical valve implantations were performed by Osaka University last month in preparation for Osaka’s Senshin-Iryo application submission to the Japanese Ministry of Health, Labour and Welfare.

November 6, 2009 – Nearly 4 million people nationwide suffer from cardiac arrhythmias each year, according to the 2006 U.S. Cardiac Rhythm Management Market report by Frost and Sullivan. About 2.5 million of these cases cannot be treated or controlled through medication alone.

November 6, 2009 – Cardiac support device maker Abiomed Inc. yesterday announced second quarter fiscal 2010 revenue of $20 million.

The Carotid Intima-Media Thickness (CIMT) Screening, which maps and assesses vascular age, is one of the many easily configurable study types within the Digisonics DigiView Image Management and Reporting System.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now